GSK announce meningitis vaccine for Africa
British pharmaceutical giant GlaxoSmithKline (GSK) have announced the development of a vaccine for use in African meningitis belt countries that the company says will never make a profit or even recoup its R&D costs. The vaccine is Globorixâ„¢, primarily a…